(Total Views: 317)
Posted On: 09/30/2025 5:44:38 PM
Post# of 157600
Probably not done often by pre-revenue, clinical stage pharma. Most would need an exclusive deal.
LL has many indications besides the ones that help ICI do better.
So we can work non-exclusive arrangements across the platform.
Get in line or step up BP.
LL has many indications besides the ones that help ICI do better.
So we can work non-exclusive arrangements across the platform.
Get in line or step up BP.
(3)
(0)
